PINION JOHN RICHARD (See Remarks) sold 4.5% of their position (4.17K shares) of ULTRAGENYX PHARMACEUTICAL INC. on the open market
Open‑market sale worth $224.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/5/2024ACC: 0000950170-24-026648
Officer· See Remarks
Since Mar 2026
+45.92K
Net shares
Net buyer
$227.6K
Total sold
1
Open market trades
0B · 1S
5
Total transactions
50.16K acquired · 4.23K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+17.80K
Price / share
—
Trade value
—
% of position
23.8%
3/1/2024
74.74K→92.54K
Common Stock
Direct
Shares
+957.00
Price / share
—
Trade value
—
% of position
1.0%
3/1/2024
92.54K→93.50K
Common Stock
Direct
Shares
−60.00
Price / share
$53.69
Trade value
$3.22K
% of position
0.1%
3/1/2024
93.50K→93.44K
Common Stock
Direct
Shares
−4.17K
Price / share
$53.76
Trade value
$224.34K
% of position
4.5%
3/1/2024
93.44K→89.27K
Total
Net shares
+14.52K
Net value
-$227.56K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2024 | A · Award | +17.80K | — | — | 23.8% | 74.74K | 92.54K |
| Common Stock Direct | 3/1/2024 | A · Award | +957.00 | — | — | 1.0% | 92.54K | 93.50K |
| Common Stock Direct | 3/1/2024 | F · Tax Withholding | −60.00 | $53.69 | $3.22K | 0.1% | 93.50K | 93.44K |
| Common Stock Direct | 3/1/2024 | S · Sale | −4.17K | $53.76 | $224.34K | 4.5% | 93.44K | 89.27K |
| Total | +14.52K | -$227.56K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
31.40K shares
Shares
+31.40K
Strike price
53.69
Held after
31.40K
Exercisable
—
3/1/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock31.40K shares | 3/1/2024 | A · Award | +31.40K | 53.69 | — | 31.40K |